Delivery Order SPE2DB25D3017-SPE2DB25FVKAA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 on August 1, 2025, for the supply of Calquence 100 mg tablets (60 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and performance to be fulfilled at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the company's...
- AmerisourceBergen Drug Corp was awarded a $11,187.56 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract carries an ultimate completion date of September 3, 2025, and represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Calquence 100 mg tablets (60-count units) with an ultimate completion date of August 8, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Calquence 100 mg tablets (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Calquence 100 mg tablets (60-count package) valued at $11,187.56. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on July 25, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a firm fixed price ceiling value of $5,593.77 and an ultimate completion date of August 15, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Calquence 100 mg tablets (60 count). This is a non-set-aside contract with an ultimate completion date of August 20, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Calquence 100 mg tablets (60-count packages). This contract utilizes a firm fixed price model with an ultimate completion date of August 12, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKAADelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,593.77 by the Defense Logistics Agency to supply 60 tablets of Calquence 100 mg, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania. The contract, executed on July 28, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC represents a strategic partnership enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical commodities such as specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. The Defense Logistics Agency's medical supply chain regularly issues delivery orders under this vehicle to fulfill ongoing pharmaceutical needs for the Defense Health Agency and related government healthcare systems. AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition, combined with its substantial IDC capacity, positions the company as a significant pharmaceutical distributor for Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/28/25 |